September 4 – Researchers at and associated with the International AIDS Vaccine Initiative (IAVI), at The Scripps Research Institute, and at the biotechnology companies Theraclone Sciences

April 21- QIAGEN and the Chittaranjan National Cancer Institute (CNCI) today announced a collaboration to establish the first large-scale cervical cancer

April 1 – Results from an eight-year trial involving more than 130,000 women published today in The New England Journal of Medicine (NEJM)

March 24 – Physicians from Kaiser Permanente and the National Cancer Institute report in the March issue of Obstetrics & Gynecology that results from an evaluation of more

May 27 – Favrille, Inc. (NASDAQ:FVRL) today announced results from the Company’s Phase 3 registration trial of Specifid(TM) following Rituxan(R) in patients with follicular B-cell non-Hodgkin’s lymphoma (NHL).

May 27 – Impliant, Inc., a developer of novel spine arthroplasty alternatives to fusion surgery, today announced that it has received FDA approval to restart patient enrollment in a pivotal IDE trial of its

May 27 – Cardium Therapeutics and its subsidiary, Tissue Repair Company (TRC) today announced the launch of a new website at http://www.diabeticfootstudy.com/ to provide patients, caregivers and physicians with information about the Company’s Phase 2B MATRIX clinical study.

Aug. 15 : Millennium Pharmaceuticals, Inc. today announced the initiation of a randomized, multi-center, Company-sponsored Phase II trial to evaluate the efficacy of combining